| Affirmed Counseling, Pllc | |
|
323 Yadkin St Albemarle NC 28001-3441 | |
| (704) 550-5781 | |
| (704) 870-3932 |
| Full Name | Affirmed Counseling, Pllc |
|---|---|
| Speciality | Counselor |
| Location | 323 Yadkin St, Albemarle, North Carolina |
| Authorized Official Name and Position | Elizabeth J Ritter (OWNER) |
| Authorized Official Contact | 6107042853 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Affirmed Counseling, Pllc 323 Yadkin St Albemarle NC 28001-3441 Ph: (704) 550-5781 | Affirmed Counseling, Pllc 323 Yadkin St Albemarle NC 28001-3441 Ph: (704) 550-5781 |
| NPI Number | 1184114910 |
|---|---|
| Provider Enumeration Date | 05/17/2018 |
| Last Update Date | 09/29/2022 |
| Certification Date | 09/29/2022 |
| Medicare PECOS PAC ID | 5799197984 |
|---|---|
| Medicare Enrollment ID | O20201211001287 |
News Archive
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.
Newborn babies seem to hiccup a lot and there are myths and legends surrounding such behaviour. Now researchers have found that with each such hiccup in a new born, there is a trigger of brain signals that help the baby's brain figure out breathing. The UCL scientists published the findings of their study in the latest issue of the journal Clinical Neurophysiology.
Forge Therapeutics, Inc., a biotechnology company developing innovative medicines using a breakthrough drug discovery platform targeting metalloproteins, announced today it has obtained an exclusive license from the University of California San Diego to patent rights related to novel metalloprotein inhibitors discovered in the laboratory of Forge Therapeutics scientific co-founder Professor Seth Cohen, Ph.D.
A Massachusetts General Hospital study has found the mechanism by which amyloid beta - the protein deposited into plaques in the brains of patients with Alzheimer's disease - protects from the effects of herpes viruses commonly found in the brain.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184114910 | NPI | - | NPPES |
| 33842 | Medicaid | NC |
| Provider Name | Rashonda Wheeler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669090213 PECOS PAC ID: 6709298904 Enrollment ID: I20201211001794 |
News Archive
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.
Newborn babies seem to hiccup a lot and there are myths and legends surrounding such behaviour. Now researchers have found that with each such hiccup in a new born, there is a trigger of brain signals that help the baby's brain figure out breathing. The UCL scientists published the findings of their study in the latest issue of the journal Clinical Neurophysiology.
Forge Therapeutics, Inc., a biotechnology company developing innovative medicines using a breakthrough drug discovery platform targeting metalloproteins, announced today it has obtained an exclusive license from the University of California San Diego to patent rights related to novel metalloprotein inhibitors discovered in the laboratory of Forge Therapeutics scientific co-founder Professor Seth Cohen, Ph.D.
A Massachusetts General Hospital study has found the mechanism by which amyloid beta - the protein deposited into plaques in the brains of patients with Alzheimer's disease - protects from the effects of herpes viruses commonly found in the brain.
› Verified 1 days ago
| Provider Name | Desiree Godlyn Akpan |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1366030454 PECOS PAC ID: 7517362262 Enrollment ID: I20210819000039 |
News Archive
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.
Newborn babies seem to hiccup a lot and there are myths and legends surrounding such behaviour. Now researchers have found that with each such hiccup in a new born, there is a trigger of brain signals that help the baby's brain figure out breathing. The UCL scientists published the findings of their study in the latest issue of the journal Clinical Neurophysiology.
Forge Therapeutics, Inc., a biotechnology company developing innovative medicines using a breakthrough drug discovery platform targeting metalloproteins, announced today it has obtained an exclusive license from the University of California San Diego to patent rights related to novel metalloprotein inhibitors discovered in the laboratory of Forge Therapeutics scientific co-founder Professor Seth Cohen, Ph.D.
A Massachusetts General Hospital study has found the mechanism by which amyloid beta - the protein deposited into plaques in the brains of patients with Alzheimer's disease - protects from the effects of herpes viruses commonly found in the brain.
› Verified 1 days ago
| Provider Name | Karen Wells |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932649506 PECOS PAC ID: 7315339314 Enrollment ID: I20220125002589 |
News Archive
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.
Newborn babies seem to hiccup a lot and there are myths and legends surrounding such behaviour. Now researchers have found that with each such hiccup in a new born, there is a trigger of brain signals that help the baby's brain figure out breathing. The UCL scientists published the findings of their study in the latest issue of the journal Clinical Neurophysiology.
Forge Therapeutics, Inc., a biotechnology company developing innovative medicines using a breakthrough drug discovery platform targeting metalloproteins, announced today it has obtained an exclusive license from the University of California San Diego to patent rights related to novel metalloprotein inhibitors discovered in the laboratory of Forge Therapeutics scientific co-founder Professor Seth Cohen, Ph.D.
A Massachusetts General Hospital study has found the mechanism by which amyloid beta - the protein deposited into plaques in the brains of patients with Alzheimer's disease - protects from the effects of herpes viruses commonly found in the brain.
› Verified 1 days ago
| Provider Name | Kristen Daniels |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1902351869 PECOS PAC ID: 7012383458 Enrollment ID: I20221026001142 |
News Archive
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.
Newborn babies seem to hiccup a lot and there are myths and legends surrounding such behaviour. Now researchers have found that with each such hiccup in a new born, there is a trigger of brain signals that help the baby's brain figure out breathing. The UCL scientists published the findings of their study in the latest issue of the journal Clinical Neurophysiology.
Forge Therapeutics, Inc., a biotechnology company developing innovative medicines using a breakthrough drug discovery platform targeting metalloproteins, announced today it has obtained an exclusive license from the University of California San Diego to patent rights related to novel metalloprotein inhibitors discovered in the laboratory of Forge Therapeutics scientific co-founder Professor Seth Cohen, Ph.D.
A Massachusetts General Hospital study has found the mechanism by which amyloid beta - the protein deposited into plaques in the brains of patients with Alzheimer's disease - protects from the effects of herpes viruses commonly found in the brain.
› Verified 1 days ago
News Archive
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.
Newborn babies seem to hiccup a lot and there are myths and legends surrounding such behaviour. Now researchers have found that with each such hiccup in a new born, there is a trigger of brain signals that help the baby's brain figure out breathing. The UCL scientists published the findings of their study in the latest issue of the journal Clinical Neurophysiology.
Forge Therapeutics, Inc., a biotechnology company developing innovative medicines using a breakthrough drug discovery platform targeting metalloproteins, announced today it has obtained an exclusive license from the University of California San Diego to patent rights related to novel metalloprotein inhibitors discovered in the laboratory of Forge Therapeutics scientific co-founder Professor Seth Cohen, Ph.D.
A Massachusetts General Hospital study has found the mechanism by which amyloid beta - the protein deposited into plaques in the brains of patients with Alzheimer's disease - protects from the effects of herpes viruses commonly found in the brain.
› Verified 1 days ago
Monarch Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1615 Moss Springs Rd, Albemarle, NC 28001 Phone: 704-982-5619 Fax: 704-982-3850 | |
Easter Seals Ucp North Carolina & Virginia, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2215 Waverly St, Albemarle, NC 28001 Phone: 704-983-2777 Fax: 704-983-2777 | |
Premier Service Of Carolina, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 Penny St, Albemarle, NC 28001 Phone: 704-985-1178 Fax: 704-985-0106 | |
Monarch Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 350 Pee Dee Ave, Suite 101, Albemarle, NC 28001 Phone: 704-986-1522 Fax: 704-982-5279 | |
Daymark Recovery Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1000 N 1st St, Suite 1, Albemarle, NC 28001 Phone: 704-983-2117 | |
Monarch Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1811 Badin Rd, Albemarle, NC 28001 Phone: 704-986-1500 Fax: 704-982-5279 | |
Monarch Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 730 Greenwood St, Albemarle, NC 28001 Phone: 704-986-1500 Fax: 704-982-5279 |